Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
33 results
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy
D1.156 - Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients
D1.157 - Type II Cytokine-Mediated Regulation of Alarmin Receptors in B Cells: Implications for Eosinophilic Esophagitis
D1.159 - The successful resolve of nasal polyps in patient with dupilumab treatment
D2.230 - Cross-Reactivity of Cephalosporins in Patients with IgE-Mediated Allergy to Penicillins: A Systematic Review
D2.231 - The experiences of ferric carboxymaltose desensitization and provocation
D2.232 - SDRIFE related to generalized corticosteroids’ hypersensitivity: A case report
D2.233 - Negative predictive value of skin tests with local anaesthetics
D2.235 - Is an allergy skin test with local anaesthetics necessary? Real life data with 124 patients
D2.236 - Drug-induced angioedema by racecadotril in a patient treated with angiotensin-converting enzyme inhibitors
D2.237 - Corticosteroid allergy, hypertryptasemia and renal transplant
D2.238 - Successful Prevention of Subsequent L-Asparaginase Hypersensitivity in Children through Premedication: A Single-Center Experience
D2.239 - The First Successful Desensitization in Abemaciclib Hypersensitivity: A Case Report
D2.242 - Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a Romanian University Hospital
D2.243 - From Risk to Solution: Effective Desensitization in a Confirmed Delayed Hypersensitivity Reaction to Albendazole
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download